Closing Bell: Medicenna Therapeutics Corp up on Thursday (MDNA)

Medicenna Therapeutics Corp opened trading today at $1.91 and closed at $2.13. It traded at a low of $1.91 to a high of $2.29.

Shares advanced 9.23% from the previous day's close of $1.95.

During the day across North America, the TSX Composite closed -0.14% at 22608.03, the S&P 500 closed -2.31% at 5427.13, the Dow Jones Industrial Average closed -1.25% at 39853.87 and the Nasdaq Composite closed -3.64% at 17342.41.

Medicenna Therapeutics Corp has listed on the Toronto Stock Exchange (TSX) under the ticker MDNA.

Trading volume was 211,451 on 388 total trades, with an average volume of 74,095 in the last five days.

Trading across the entire TSX saw 3,490 price advancers against 1,736 declines and 92 unchanged.

During the prior 52 weeks, MDNA.TO has traded as high as $2.98 (June 03,2024) and low as $0.22 (November 01,2023). Moreover, in the last 12 months, Medicenna Therapeutics Corp's shares have risen 334.69 percent, while they have risen 407.14% since the start of 2024.

Following today's trading, Medicenna Therapeutics Corp has a market capitalization of $145.82 million on a float of 74,779 shares outstanding. Its annual EPS is $-0.23.

Medicenna Therapeutics Corp is a TSX Biotechnology company headquartered in Toronto, CAN.

Medicenna Therapeutics Corp is holding an average recommendation of "Strong Buy" from 2.00 analysts according to Zacks. From those 2 analysts, 2 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..